Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
17.04
-0.47 (-2.68%)
At close: Apr 20, 2026, 4:00 PM EDT
16.90
-0.14 (-0.82%)
After-hours: Apr 20, 2026, 5:46 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.76 billion as of April 20, 2026. Its market cap has increased by 119.91% in one year.
Market Cap
1.76B
Enterprise Value
1.28B
1-Year Change
119.91%
Ranking
Category
Stock Price
$17.04
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.76B, an increase of 150.26%. That is a compound annual growth rate of 17.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 1.76B | -8.37% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tyra Biosciences | 1.92B |
| Rapport Therapeutics | 1.90B |
| Pharvaris | 1.87B |
| Palvella Therapeutics | 1.86B |
| Taysha Gene Therapies | 1.85B |
| Vericel | 1.82B |
| Innoviva | 1.80B |
| Nuvation Bio | 1.77B |